Financhill
Buy
58

MET Quote, Financials, Valuation and Earnings

Last price:
$81.37
Seasonality move :
0.34%
Day range:
$79.48 - $82.32
52-week range:
$64.61 - $89.05
Dividend yield:
2.65%
P/E ratio:
16.40x
P/S ratio:
0.83x
P/B ratio:
1.82x
Volume:
7.9M
Avg. volume:
3.6M
1-year change:
24.75%
Market cap:
$56.3B
Revenue:
$66.4B
EPS (TTM):
$4.96

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MET
MetLife
$18.4B $2.18 0.36% 187.48% $92.54
AFL
Aflac
$4.5B $1.68 9.56% 252.58% $105.77
ALL
Allstate
$15.7B $2.40 7.73% 3.28% $223.18
LNC
Lincoln National
$4.6B $1.63 550.07% -66.04% $36.09
PRI
Primerica
$745.7M $4.81 -1.18% 13.39% $309.33
PRU
Prudential Financial
$14.9B $3.48 -7.19% -6.5% $119.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MET
MetLife
$81.36 $92.54 $56.3B 16.40x $0.55 2.65% 0.83x
AFL
Aflac
$102.69 $105.77 $57B 15.47x $0.50 1.95% 3.37x
ALL
Allstate
$193.56 $223.18 $51.3B 12.54x $0.92 1.9% 0.82x
LNC
Lincoln National
$31.00 $36.09 $5.3B 22.14x $0.45 5.81% 0.39x
PRI
Primerica
$271.50 $309.33 $9.1B 20.74x $0.90 1.22% 3.04x
PRU
Prudential Financial
$117.83 $119.50 $41.9B 10.47x $1.30 4.41% 0.58x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MET
MetLife
37.9% 1.009 33.44% 448.28x
AFL
Aflac
24.06% 0.790 12.64% 25.30x
ALL
Allstate
27.91% 0.532 15.49% --
LNC
Lincoln National
39.9% 1.432 94.18% 5.24x
PRI
Primerica
49.71% 1.575 21.66% 9.45x
PRU
Prudential Financial
41.39% 1.156 52.08% 4.74x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MET
MetLife
-- -- 7.91% 13.1% 12.33% $4.2B
AFL
Aflac
-- -- 12.2% 16% 4.68% $1.3B
ALL
Allstate
-- -- 16.27% 23.5% 9.15% $3.1B
LNC
Lincoln National
-- -- 2.73% 5.12% -14.7% -$27M
PRI
Primerica
-- -- 11.13% 21.41% 33.67% $193.2M
PRU
Prudential Financial
-- -- 8.08% 13.78% 2.83% $1.1B

MetLife vs. Competitors

  • Which has Higher Returns MET or AFL?

    Aflac has a net margin of 7.35% compared to MetLife's net margin of -3.06%. MetLife's return on equity of 13.1% beat Aflac's return on equity of 16%.

    Company Gross Margin Earnings Per Share Invested Capital
    MET
    MetLife
    -- $1.81 $50B
    AFL
    Aflac
    -- -$0.17 $32.7B
  • What do Analysts Say About MET or AFL?

    MetLife has a consensus price target of $92.54, signalling upside risk potential of 13.74%. On the other hand Aflac has an analysts' consensus of $105.77 which suggests that it could grow by 3%. Given that MetLife has higher upside potential than Aflac, analysts believe MetLife is more attractive than Aflac.

    Company Buy Ratings Hold Ratings Sell Ratings
    MET
    MetLife
    7 2 0
    AFL
    Aflac
    1 8 1
  • Is MET or AFL More Risky?

    MetLife has a beta of 1.065, which suggesting that the stock is 6.465% more volatile than S&P 500. In comparison Aflac has a beta of 0.973, suggesting its less volatile than the S&P 500 by 2.728%.

  • Which is a Better Dividend Stock MET or AFL?

    MetLife has a quarterly dividend of $0.55 per share corresponding to a yield of 2.65%. Aflac offers a yield of 1.95% to investors and pays a quarterly dividend of $0.50 per share. MetLife pays 111.79% of its earnings as a dividend. Aflac pays out 20.73% of its earnings as a dividend. Aflac's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but MetLife's is not.

  • Which has Better Financial Ratios MET or AFL?

    MetLife quarterly revenues are $18.3B, which are larger than Aflac quarterly revenues of $3B. MetLife's net income of $1.3B is higher than Aflac's net income of -$93M. Notably, MetLife's price-to-earnings ratio is 16.40x while Aflac's PE ratio is 15.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MetLife is 0.83x versus 3.37x for Aflac. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MET
    MetLife
    0.83x 16.40x $18.3B $1.3B
    AFL
    Aflac
    3.37x 15.47x $3B -$93M
  • Which has Higher Returns MET or ALL?

    Allstate has a net margin of 7.35% compared to MetLife's net margin of 7.16%. MetLife's return on equity of 13.1% beat Allstate's return on equity of 23.5%.

    Company Gross Margin Earnings Per Share Invested Capital
    MET
    MetLife
    -- $1.81 $50B
    ALL
    Allstate
    -- $4.33 $28.9B
  • What do Analysts Say About MET or ALL?

    MetLife has a consensus price target of $92.54, signalling upside risk potential of 13.74%. On the other hand Allstate has an analysts' consensus of $223.18 which suggests that it could grow by 15.3%. Given that Allstate has higher upside potential than MetLife, analysts believe Allstate is more attractive than MetLife.

    Company Buy Ratings Hold Ratings Sell Ratings
    MET
    MetLife
    7 2 0
    ALL
    Allstate
    6 4 1
  • Is MET or ALL More Risky?

    MetLife has a beta of 1.065, which suggesting that the stock is 6.465% more volatile than S&P 500. In comparison Allstate has a beta of 0.504, suggesting its less volatile than the S&P 500 by 49.607%.

  • Which is a Better Dividend Stock MET or ALL?

    MetLife has a quarterly dividend of $0.55 per share corresponding to a yield of 2.65%. Allstate offers a yield of 1.9% to investors and pays a quarterly dividend of $0.92 per share. MetLife pays 111.79% of its earnings as a dividend. Allstate pays out -548.94% of its earnings as a dividend.

  • Which has Better Financial Ratios MET or ALL?

    MetLife quarterly revenues are $18.3B, which are larger than Allstate quarterly revenues of $16.6B. MetLife's net income of $1.3B is higher than Allstate's net income of $1.2B. Notably, MetLife's price-to-earnings ratio is 16.40x while Allstate's PE ratio is 12.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MetLife is 0.83x versus 0.82x for Allstate. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MET
    MetLife
    0.83x 16.40x $18.3B $1.3B
    ALL
    Allstate
    0.82x 12.54x $16.6B $1.2B
  • Which has Higher Returns MET or LNC?

    Lincoln National has a net margin of 7.35% compared to MetLife's net margin of -12.58%. MetLife's return on equity of 13.1% beat Lincoln National's return on equity of 5.12%.

    Company Gross Margin Earnings Per Share Invested Capital
    MET
    MetLife
    -- $1.81 $50B
    LNC
    Lincoln National
    -- -$3.29 $15B
  • What do Analysts Say About MET or LNC?

    MetLife has a consensus price target of $92.54, signalling upside risk potential of 13.74%. On the other hand Lincoln National has an analysts' consensus of $36.09 which suggests that it could grow by 16.42%. Given that Lincoln National has higher upside potential than MetLife, analysts believe Lincoln National is more attractive than MetLife.

    Company Buy Ratings Hold Ratings Sell Ratings
    MET
    MetLife
    7 2 0
    LNC
    Lincoln National
    1 10 0
  • Is MET or LNC More Risky?

    MetLife has a beta of 1.065, which suggesting that the stock is 6.465% more volatile than S&P 500. In comparison Lincoln National has a beta of 1.774, suggesting its more volatile than the S&P 500 by 77.395%.

  • Which is a Better Dividend Stock MET or LNC?

    MetLife has a quarterly dividend of $0.55 per share corresponding to a yield of 2.65%. Lincoln National offers a yield of 5.81% to investors and pays a quarterly dividend of $0.45 per share. MetLife pays 111.79% of its earnings as a dividend. Lincoln National pays out -51.46% of its earnings as a dividend.

  • Which has Better Financial Ratios MET or LNC?

    MetLife quarterly revenues are $18.3B, which are larger than Lincoln National quarterly revenues of $4.2B. MetLife's net income of $1.3B is higher than Lincoln National's net income of -$528M. Notably, MetLife's price-to-earnings ratio is 16.40x while Lincoln National's PE ratio is 22.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MetLife is 0.83x versus 0.39x for Lincoln National. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MET
    MetLife
    0.83x 16.40x $18.3B $1.3B
    LNC
    Lincoln National
    0.39x 22.14x $4.2B -$528M
  • Which has Higher Returns MET or PRI?

    Primerica has a net margin of 7.35% compared to MetLife's net margin of 21.23%. MetLife's return on equity of 13.1% beat Primerica's return on equity of 21.41%.

    Company Gross Margin Earnings Per Share Invested Capital
    MET
    MetLife
    -- $1.81 $50B
    PRI
    Primerica
    -- $4.83 $3.9B
  • What do Analysts Say About MET or PRI?

    MetLife has a consensus price target of $92.54, signalling upside risk potential of 13.74%. On the other hand Primerica has an analysts' consensus of $309.33 which suggests that it could grow by 13.94%. Given that Primerica has higher upside potential than MetLife, analysts believe Primerica is more attractive than MetLife.

    Company Buy Ratings Hold Ratings Sell Ratings
    MET
    MetLife
    7 2 0
    PRI
    Primerica
    2 6 0
  • Is MET or PRI More Risky?

    MetLife has a beta of 1.065, which suggesting that the stock is 6.465% more volatile than S&P 500. In comparison Primerica has a beta of 1.090, suggesting its more volatile than the S&P 500 by 8.951%.

  • Which is a Better Dividend Stock MET or PRI?

    MetLife has a quarterly dividend of $0.55 per share corresponding to a yield of 2.65%. Primerica offers a yield of 1.22% to investors and pays a quarterly dividend of $0.90 per share. MetLife pays 111.79% of its earnings as a dividend. Primerica pays out 16.25% of its earnings as a dividend. Primerica's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but MetLife's is not.

  • Which has Better Financial Ratios MET or PRI?

    MetLife quarterly revenues are $18.3B, which are larger than Primerica quarterly revenues of $774.1M. MetLife's net income of $1.3B is higher than Primerica's net income of $164.4M. Notably, MetLife's price-to-earnings ratio is 16.40x while Primerica's PE ratio is 20.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MetLife is 0.83x versus 3.04x for Primerica. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MET
    MetLife
    0.83x 16.40x $18.3B $1.3B
    PRI
    Primerica
    3.04x 20.74x $774.1M $164.4M
  • Which has Higher Returns MET or PRU?

    Prudential Financial has a net margin of 7.35% compared to MetLife's net margin of 2.29%. MetLife's return on equity of 13.1% beat Prudential Financial's return on equity of 13.78%.

    Company Gross Margin Earnings Per Share Invested Capital
    MET
    MetLife
    -- $1.81 $50B
    PRU
    Prudential Financial
    -- $1.24 $54.1B
  • What do Analysts Say About MET or PRU?

    MetLife has a consensus price target of $92.54, signalling upside risk potential of 13.74%. On the other hand Prudential Financial has an analysts' consensus of $119.50 which suggests that it could grow by 10.13%. Given that MetLife has higher upside potential than Prudential Financial, analysts believe MetLife is more attractive than Prudential Financial.

    Company Buy Ratings Hold Ratings Sell Ratings
    MET
    MetLife
    7 2 0
    PRU
    Prudential Financial
    2 12 0
  • Is MET or PRU More Risky?

    MetLife has a beta of 1.065, which suggesting that the stock is 6.465% more volatile than S&P 500. In comparison Prudential Financial has a beta of 1.296, suggesting its more volatile than the S&P 500 by 29.613%.

  • Which is a Better Dividend Stock MET or PRU?

    MetLife has a quarterly dividend of $0.55 per share corresponding to a yield of 2.65%. Prudential Financial offers a yield of 4.41% to investors and pays a quarterly dividend of $1.30 per share. MetLife pays 111.79% of its earnings as a dividend. Prudential Financial pays out 74.2% of its earnings as a dividend. Prudential Financial's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but MetLife's is not.

  • Which has Better Financial Ratios MET or PRU?

    MetLife quarterly revenues are $18.3B, which are smaller than Prudential Financial quarterly revenues of $19.5B. MetLife's net income of $1.3B is higher than Prudential Financial's net income of $448M. Notably, MetLife's price-to-earnings ratio is 16.40x while Prudential Financial's PE ratio is 10.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MetLife is 0.83x versus 0.58x for Prudential Financial. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MET
    MetLife
    0.83x 16.40x $18.3B $1.3B
    PRU
    Prudential Financial
    0.58x 10.47x $19.5B $448M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 6.55% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.29% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock